JPMorgan Chase Cuts DENTSPLY SIRONA Stock Position by 19%

Institutional investor reduces stake in medical instruments supplier

Apr. 2, 2026 at 8:52am

Got story updates? Submit your updates here. ›

JPMorgan Chase & Co. has reduced its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 19.1% in the third quarter, according to the company's latest SEC filing. The institutional investor now owns approximately 416,856 shares of the medical instruments supplier's stock, valued at $5.29 million.

Why it matters

This move by a major institutional investor like JPMorgan Chase could signal broader market sentiment and trends around DENTSPLY SIRONA's stock performance and the overall outlook for the medical devices industry.

The details

According to the filing, JPMorgan Chase sold 98,640 shares of DENTSPLY SIRONA during the third quarter, reducing its total position to 416,856 shares. The company cited the medical instruments supplier's stock performance as the reason for the reduction in its holdings.

  • JPMorgan Chase made the stock sale in the third quarter of the fiscal year.

The players

JPMorgan Chase & Co.

A multinational investment bank and financial services company headquartered in New York City.

DENTSPLY SIRONA Inc.

A leading global manufacturer of professional dental products and technologies, headquartered in Charlotte, North Carolina.

Got photos? Submit your photos here. ›

The takeaway

This reduction in JPMorgan Chase's position in DENTSPLY SIRONA could signal broader market concerns about the medical devices company's stock performance and the overall outlook for the industry. Investors will be closely watching to see if other major institutional investors follow suit.